Numerai’s Usana Health Sciences USNA Stock Holding History

Numerai’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$502K	Sell	28,726 -23,602	-45%	-$468K	0.05%	520
2025 Q4	$1.03M	Buy	+52,328	New	+$1.09M	0.12%	240
2025 Q3	–	Sell	-11,430	Closed	-$349K	–	671
2025 Q2	$349K	Sell	11,430 -10,558	-48%	-$300K	0.05%	347
2025 Q1	$593K	Sell	21,988 -42,266	-66%	-$1.34M	0.11%	257
2024 Q4	$2.31M	Sell	64,254 -3,478	-5%	-$130K	0.63%	34
2024 Q3	$2.57M	Buy	+67,732	New	+$2.78M	0.68%	34

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Numerai's USNA Position: Q1 2026 in Review

Numerai reduced its Usana Health Sciences (USNA) stake by 45% in Q1 2026, selling an estimated $468K and leaving 28,726 shares worth $502K. The position accounts for 0.05% of the portfolio, ranked #520.

Numerai first reported a position in USNA in Q3 2024 and has held it in 6 quarters since. The position peaked at $2.57M in Q3 2024. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

Numerai held 28,726 shares of Usana Health Sciences worth $502K as of Q1 2026.
Numerai sold 23,602 Usana Health Sciences shares in Q1 2026, an estimated $468K.
Usana Health Sciences made up 0.05% of Numerai's portfolio in Q1 2026, its #520 holding.
Numerai first reported a position in Usana Health Sciences in Q3 2024 and has held it in 6 quarters since.
Numerai's Usana Health Sciences position peaked at $2.57M in Q3 2024.
139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Numerai's 13F filing for Q1 2026, filed 15 May 2026.